| Previous Section | Index | Home Page |
Departmental Employees
Mr. Fisher: To ask the Secretary of State for Health if he will list those (a) consultants, (b) outside organisations and (c) individuals employed by his Department in each year since 1990, indicating the purposes of their employment and the total payments made to them. [3959]
Mr. Horam: Information about each consultant and outside organisation employed by the Department of Health since 1990 and the total payments to them could be provided only at disproportionate cost. Details of individuals employed by the Department are contained in the civil service staff post summary tables, copies of which are available in the Library. Staffing costs since 1990 can be found in the relevant copies of the departmental report.
The purpose of employing consultants, outside organisations and individuals was and is to assist the Department in achieving its aims and objectives as set out in the departmental reports.
Health Authorities
Mr. Milburn: To ask the Secretary of State for Health if he will list all health authorities with effect from 1 April 1996. [4063]
Mr. Malone: I refer the hon. Member to the reply I gave my hon. Friend the Member for Hexham (Mr. Atkinson) on 23 November, Official Report, column 331, concerning the new health authorities.
Ms Harman: To ask the Secretary of State for Health what is the budget for each health authority in (a) 1994-95 and (b) 1995-96. [4966]
Mr. Horam [holding answer 8 December 1995]: 1994-95 final revenue cash limits and 1995-96 initial revenue cash limits for each district health authority will be placed in the Library.
Breast Cancer
Mrs. Clwyd: To ask the Secretary of State for Health how much money was spent on breast cancer research in each year since 1989-90 by the Government. [4004]
11 Dec 1995 : Column: 518
Mr. Malone: The figures are shown in the table:
| Thousands | |
|---|---|
| 1990-91 | 3,220 |
| 1991-92 | 2,139 |
| 1992-93 | 3,791 |
| 1993-94 | 3,948 |
| 1994-95 | 4,284 |
Committee on Safety of Medicines
Mr. Simon Hughes: To ask the Secretary of State for Health (1) at what date and time the Committee on Safety of Medicines met to consider safety issues relating to the third generation oral contraceptive; [4301]
(2) at what date and time papers relating to potential safety concerns about third generation oral contraceptives were first made available to all members of the Committee on Safety of Medicines. [4302]
Mr. Malone: The Committee on Safety of Medicines met on Friday 13 October at 10 am to consider the issues relating to third generation oral contraceptives. The papers for the meeting were dispatched to all members of the committee at 4 pm on 11 October by express courier service and were received by members at 10.30 am the following morning. Prior to this, some members of the CSM and expert external advisers had met on 10 October to consider the papers. Some advisers were also provided with each element of the data as it became available and a series of meetings were held to discuss the evidence as it evolved between June and October.
Prior to the availability of the new epidemiological evidence on third generation oral contraceptives, the CSM had reviewed the safety of third generation oral contraceptives and gestodene-based oral contraceptives in particular on three occasions, in 1989, 1991 and 1995.
Mr. Hughes:
To ask the Secretary of State for Health if he will list the costs, including travel costs and emoluments, of supporting the sub-committees of the Committee on Safety of Medicines, for each year since 1991. [4306]
Mr. Malone:
The information requested in respect of the sub-committtees of the Committee on Safety of Medicines--biologicals, chemistry, pharmacy and standards, pharmacovigilance and safety and efficacy--is as shown in the table for each financial year since 1990-91. The figures include members' fees, travel, hotel, and other miscellaneous costs.
Mr. Hughes:
To ask the Secretary of State for Health (1) if he will list the names, professional appointments, date of first appointment to the Committee on Safety of Medicines and the total duration of membership of each member of the Committee on Safety of Medicines as at 1 October; [4304]
1990-91: £116,265.26
1991-92: £120,427.43
1992-93: £113,874.82
1993-94: £121,778.89
1994-95: £92,741.42.
- (2) how many members of the Committee on Safety of Medicines have a qualification in epidemiology. [4303]
11 Dec 1995 : Column: 519
Mr. Malone: The membership of the Committee on Safety of Medicines and information requested is shown in the table. Dr. Janet Darbyshire has a formal epidemiological qualification and in addition Professor M. D. Rawlins, chairman, and Professor M. J. S. Langman have extensive experience in pharmacoepidemiology.
11 Dec 1995 : Column: 520
The committee consults as necessary other disciplines not represented on the committee, including experts in epidemiology, and when the need arises co-opts them on to the committee as "members for the day". The sub-committees of the Committee on Safety of Medicines additionally provide a range of expertise which may not be represented on the main committee.
11 Dec 1995 : Column: 519
| Name | Professional appointment | Appointed | Duration until 1 October 1995 |
|---|---|---|---|
| Professor M. D. Rawlins (Chairman) | Professor of Clinical Pharmacology-- Newcastle University | January 1980 | 15 years 9 months |
| Professor A. M. Breckenridge | Professor of Clinical Pharmacology-- Liverpool University | January 1981 | 12 years 9 months |
| Dr. Kate L. Costeloe | Reader in Neonatal Paediatrics, University of London Medical College | January 1993 | 2 years 9 months |
| Dr. Janet H. Darbyshire | Head of MRC's HIV Clinical Trials Centre Hon. Consultant in Thoracic Medicine and Hon. Senior Lecturer in Epidermiology, University College London Medical School | January 1993 | 2 years 9 months |
| Professor D. S. Davies | Professor of Biochemical Pharmacology at Royal Postgraduate Medical School Hammersmith Hospital | January 1993 | 2 years 9 months |
| Professor Anne Ferguson | Professor of Gastroenterology and Head of Department of Medicine--Edinburgh University | January 1993 | 2 years 9 months |
| Professor A. T. Florence | Dean of the School of Pharmacy-- London University | January 1981 | 14 years 9 months |
| Professor A. M. Geddes | Head of Department of Infection-- Birmingham University | January 1993 | 2 years 9 months |
| Professor E. C. Gordon-Smith | Professor of Haematology--St. George's Hospital Medical School, London | January 1990 | 5 years 9 months |
| Professor K. Gull | Director of the Research and Graduate School, School of Biological Sciences, Manchester University | January 1993 | 2 years 9 months |
| Professor H. S. Jacobs | Professor of Reproductive Endocrinology, University College and Middlesex School of Medicine | January 1984 | 11 years 9 months |
| Dr. W. A. Jerrett | General Practitioner--Glamorgan | January 1987 | 8 years 9 months |
| Dr. B. J. Kirby | Consultant Physician and Deputy Director of the Postgraduate Medical School--Exeter University | January 1993 | 2 years 9 months |
| Miss Gillian C. N. Lachelin | Reader and Consultant Obstetrician and Gynaecologist--University College and Middlesex School of Medicine | January 1993 | 2 years 9 months |
| Professor M. J. S. Langman | Professor of Medicine and Dean of the Faculty of Medicine and Dentistry-- Birmingham University | January 1987 | 8 years 9 months |
| Dr. A. V. P. Mackay | Medical Director of the Argyll and Bute NHS Trust and McIntosh Lecturer in Psychological Medicine--Glasgow University | January 1993 | 2 years 9 months |
| Professor J. M. Midgley | Professor of Pharmaceutical and Medicinal Chemistry-Strathclyde University | January 1990 | 5 years 9 months |
| Professor B. K. Park | Professor of Pharmacology and Therapeutics--Liverpool University | January 1993 | 2 years 9 months |
| Professor J. C. Petrie | Professor of Clinical Pharmacology-- Aberdeen University | January 1993 | 2 years 9 months |
| Professor A. Li Wan PO | Professor of Clinical Pharmaceutics-- Nottingham University | January 1993 | 2 years 9 months |
| Professor Anne E. Tattersfield | Professor of Respiratory Medicine-- Nottingham University | January 1993 | 2 years 9 months |
11 Dec 1995 : Column: 519
Mr. Hughes: To ask the Secretary of State for Health if he will list the remuneration which the chairman and members of the Committee on Safety of Medicines received in respect of their work on the committee the last year for which figures are available. [4307]
11 Dec 1995 : Column: 520
Mr. Malone: For the financial year 1994-95, the chairman received £2,358 in attendance and preparation fees and the members received among them £34,294 in attendance and preparation fees in respect of 11 one-day meetings. In addition, the chairman and members were
11 Dec 1995 : Column: 521
reimbursed their travel, hotel and other miscellaneous cost.
Mr. Hughes: To ask the Secretary of State for Health what statutory provisions govern the Committee on Safety of Medicines. [4305]
Mr. Malone: The Committee on Safety of Medicines is a committee established by Ministers under powers in section 4 of the Medicines Act 1968. The committee was established by the Medicines (Committee on Safety of Medicines) Order 1970, S.I. 1970/1257, to give advice-- with respect to safety, quality and efficacy--on medicinal products for human use and to promote the collection and investigation of information about adverse reactions, to enable such advice to be given.
| Next Section | Index | Home Page |